Compare YieldMax NVDA Option Income Strategy ETF (NVDY) vs Oruka Therapeutics Inc. Common Stock (ORKA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
YieldMax NVDA Option Income Strategy ETF vs Oruka Therapeutics Inc. Common Stock — how do they compare? YieldMax NVDA Option Income Strategy ETF trades at $11.86 (market cap $1.40B), while Oruka Therapeutics Inc. Common Stock trades at $76.8 (market cap $5.08B). The key difference: Oruka Therapeutics Inc. Common Stock is far larger — about 3.6× YieldMax NVDA Option Income Strategy ETF's market cap, and Oruka Therapeutics Inc. Common Stock is trading nearer its 52-week high, YieldMax NVDA Option Income Strategy ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold YieldMax NVDA Option Income Strategy ETF for 44 Days and Oruka Therapeutics Inc. Common Stock for 0 Days on average.
| NVDY | ORKA | |
|---|---|---|
Market Cap | $1.40B | $5.08B |
Volume | 2,169,907 | 685,276 |
Sector | Income / Options Overlay | Health |
52-Week High | $17.21 | $113.08 |
52-Week Low | $11.58 | $26.19 |
Typical Hold Time | 44 Days | 0 Days |
Enterprise Value | — | $4.21B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NVDY trades at $12.54, up 0.88% today, but faces bearish technical signals with 18 sell indicators versus 4 buy signals. The ETF generates weekly dividend distributions but has seen analyst downgrades due to concerns about NAV erosion and capped upside participation. Recent news highlights structural limitations despite strong underlying Nvidia performance.
The outlook remains cautious as declining volatility in Nvidia reduces option income potential. While distributions provide income, the fund's strategy limits long-term capital appreciation. Key risks include NAV erosion and reduced upside capture compared to direct Nvidia ownership.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About YieldMax NVDA Option Income Strategy ETF
NVDY is an actively managed ETF that pursues a synthetic covered call strategy on NVIDIA Corporation (NVDA) stock. The fund primarily sells call options on NVDA and invests in U.S. Treasury securities and other high-quality collateral. Its goal is to generate monthly income from the option premiums. This strategy provides exposure to the high-growth potential of NVDA while seeking to deliver a high yield, though it caps the potential capital appreciation of the stock.
Read more on NVDY →About Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.
Read more on ORKA →
